United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

norgine pharmaceuticals ltd - estradiol - transdermal patch - 75microgram/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

norgine pharmaceuticals ltd - estradiol - transdermal patch - 100microgram/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

norgine pharmaceuticals ltd - estradiol - transdermal patch - 50microgram/24hour

United States - English - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - patch, extended release - 4 mg - estraderm® (estradiol transdermal system) is indicated in: - treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. - prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.    the mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin d intake, and when indicated, pharmacologic therapy. postmenopausal women require an average of 1500 mg/day of elemental calcium. therefore, when not contraindic

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - estramustine sodium phosphate monohydrate 156,7 mg - eq. estramustine phosphate 140 mg - capsule, hard - 140 mg - estramustine disodium phosphate monohydrate 156.7 mg - estramustine

Canada - English - Health Canada

novartis pharmaceuticals canada inc - estradiol - patch (extended release) - 8mg - estradiol 8mg - estrogens

Canada - English - Health Canada

novartis pharmaceuticals canada inc - estradiol - patch (extended release) - 2mg - estradiol 2mg - estrogens

Canada - English - Health Canada

novartis pharmaceuticals canada inc - estradiol - patch (extended release) - 4mg - estradiol 4mg - estrogens

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - methylprednisolone acetate - suspension for injection - 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - methylprednisolone acetate - suspension for injection - 40mg/1ml